Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages

  Dimitrow, Pawel Petkow ^a   Hlawaty, Marta ^a   Undas, Anetta ^a   Śniezek Maciejewska, Maria ^a   Sobień, Bartosz ^a   Stepień, Ewa ^a   Tracz, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aortic stenosis; Coagulation; Platelets

Indexed keywords

BETA THROMBOGLOBULIN; CD40 LIGAND; PADGEM PROTEIN; PROTHROMBIN; THROMBIN;

ADULT; AGED; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; ANTITHROMBIN III; AORTIC VALVE STENOSIS; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; BLOOD COAGULATION; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CD40 LIGAND; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; P-SELECTIN; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLATELET ACTIVATION; PROTHROMBIN; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 65649124889     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.029     Document Type: Article

References (38)

1. Novaro M., Katz R., Aviles R.J., et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 50 (2007) 1992-1998
2. Otto C.M. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 47 (2006) 2141-2151
3. Moura L.M., Ramos S.F., Zamorano J.L., et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49 (2007) 554-561
4. O'Brien K.D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26 (2006) 1721-1728
5. Vincentelli A., Susen S., Le Tourneau T., et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 349 (2003) 343-349
6. Massetti M., Babatasi G., Saloux E., et al. Spontaneous native aortic valve thrombosis. J Heart Valve Dis 8 (1999) 157-159
7. Amano H., Kubota K., Kojima A., et al. Embolism of the lower limb caused by native aortic valve thrombosis. Kyobu Geka 59 (2006) 900-903
8. Yasaka M., Tsuchiya T., and Yamaguchi T. Mobile string-like thrombus on the calcified aortic valve in cardioembolic stroke-a case report. Angiology 44 (1993) 655-659
9. Davutoglu V., Soydinc S., Celkan A., et al. Left ventricular free-floating ball thrombus complicating aortic valve stenosis. J Heart Valve Dis 13 (2004) 197-199
10. Wan S., DeSmet J.M., Vincent J.L., et al. Thrombus formation on a calcific and severely stenotic bicuspid aortic valve. Ann Thorac Surg 64 (1997) 535-536
11. Kaul H., Gutzwiller J.P., Schneider K., et al. Aortic valve stenosis as a cause of major systemic embolism-a case report. Angiology 49 (1998) 231-234
12. Kerut E.K., Dearstine M., Everson C.T., et al. Left atrial septum thrombus masquerading as a myxoma in a patient with aortic stenosis in sinus rhythm. Echocardiography 18 (2001) 709-710
13. Bilge M., Eryonucu B., and Güler N. A case of left atrial appendage thrombus with embolic stroke in association with aortic stenosis in sinus rhythm. J Am Soc Echocardiogr 13 (2000) 1127-1129
14. Fallon A.M., Dasi L.P., Marzec U.M., et al. Procoagulant properties of flow fields in stenotic and expansive orifices. Ann Biomed Eng 36 (2008) 1-13
15. Stein P.D., Sabbah H.N., and Pitha J.V. Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. Am J Cardiol 39 (1977) 159-163
16. Thrall G., and Lip G.Y. Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?. Arterioscler Thromb Vasc Biol 25 (2005) 265-267
17. Lip G.Y. Hypertension and the prothrombotic state. J Hum Hypertens 14 (2000) 687-690
18. Turitto V.T., and Hall C.L. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 92 6 Suppl. 2 (1998) S25-S31
19. Jesty J., Yin W., Perrotta P., et al. Platelet activation in circulatory loop: combined effects of shear stress and exposure time. Platelets 14 (2003) 143-149
20. Dimitrow P.P., Undas A., Bober M., et al. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 94 (2008) e21
21. Di Bello V., Giorgi D., Viacava P., et al. Severe aortic stenosis and myocardial function: diagnostic and prognostic usefulness of ultrasonic integrated backscatter analysis. Circulation 110 (2004) 849-855
22. Van Pelt N.C., Stewart R.A., Legget M.E., et al. Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis. Heart 93 (2007) 732-738
23. Teirstein P., Yeager M., Yock P.G., et al. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. J Am Coll Cardiol 8 (1986) 1059-1065
24. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007;23:75-80.
25. Goncharova N.S., Moiseeva O., and Shlyakhto E. Thrombin and P-selectin in patients with aortic stenosis. Eur Heart J 28 abstract supplement (2007) abstract 3154
26. Hathcock J.J. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol 26 (2006) 1729-1737
27. Merlini P.A., Bauer K.A., Oltrona L., et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90 (1994) 61-68
28. Giannitsis E., Bardorff M.M., Schweikart S., et al. Relationship of cardiac troponin T and procoagulant activity in unstable angina. Thromb Haemost 83 (2000) 224-228
29. Merlini P.A., Ardissino D., Oltrona L., et al. Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 15 (1995) 1675-1679
30. Falciani M., Gori A.M., Fedi S., et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 79 (1998) 495-499
31. Kienast J., Thompson S.G., Raskino C., et al. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Thromb Haemost 70 (1993) 550-553
32. van der Putten R.F., Glatz J.F., and Hermens W.T. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta 371 (2006) 37-54
33. Atak R., Yetkin E., Yetkin O., et al. Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm. Angiology 54 (2003) 593-597
34. Topaloglu S., Aras D., Ergun K., et al. Plasma level of soluble P-selectin in patients with rheumatic mitral stenosis and sinus rhythm undergoing percutaneous mitral balloon valvuloplasty. J Thromb Thrombolysis 23 (2007) 199-204
35. Undas A., Brummel-Ziedins K.E., and Mann K.G. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 109 (2007) 2285-2292
36. Walter T., Szabo S., Kazmaier S., et al. Effect of clopidogrel on adhesion molecules, hemostasis, and fibrinolysis in coronary heart disease. J Cardiovasc Pharmacol 51 (2008) 616-620
37. Miller G.J., Bauer K.A., Barzegar S., et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost 73 (1995) 82-86
38. Kario K., Matsuo T., Kobayashi H., et al. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol 37 (2001) 871-877